Suvankar Banerjee

Diamond Harbour Road, 24 Parganas West Bengal 743368 India
Diamond Harbour, WB 743368, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Recent advances in the design and development of small-molecule MMP-2 inhibitors.

Recent advances in the design and development of small-molecule MMP-2 inhibitors.

Journal: Future medicinal chemistry

Published: October 10, 2025

Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions.

Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions.

Journal: RSC medicinal chemistry

Published: September 28, 2025

Molecular modeling to simulation: insights into Gaussian QSAR, molecular docking, and DFT for identification of HDAC3 inhibitors for neurocognitive vascular dementia.

Molecular modeling to simulation: insights into Gaussian QSAR, molecular docking, and DFT for identification of HDAC3 inhibitors for neurocognitive vascular dementia.

Journal: Scientific reports

Published: September 13, 2025

PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies.

PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies.

Journal: ChemMedChem

Published: March 14, 2025

Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation.

Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation.

Journal: European journal of medicinal chemistry

Published: January 27, 2025

Fosamprenavir and Tirofiban to combat COPD and cancer: A drug repurposing strategy integrating virtual screening, MD simulation, and DFT studies.

Fosamprenavir and Tirofiban to combat COPD and cancer: A drug repurposing strategy integrating virtual screening, MD simulation, and DFT studies.

Journal: Journal of molecular graphics & modelling

Published: December 23, 2024

Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors.

Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors.

Journal: Journal of biomolecular structure & dynamics

Published: November 26, 2024

Derivatives of D(-)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis.

Derivatives of D(-)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis.

Journal: Bioorganic chemistry

Published: October 06, 2024

Unveiling structural components of dibenzofuran-based MMP-12 inhibitors: a comparative classification-dependent analysis with molecular docking-based virtual screening and molecular dynamics simulation.

Unveiling structural components of dibenzofuran-based MMP-12 inhibitors: a comparative classification-dependent analysis with molecular docking-based virtual screening and molecular dynamics simulation.

Journal: In silico pharmacology

Published: October 02, 2024

A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present).

A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present).

Journal: Expert opinion on therapeutic patents

Published: August 09, 2024

An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies.

An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies.

Journal: European journal of medicinal chemistry

Published: July 09, 2024

Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis.

Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: June 10, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026